Difference of Clinical Characteristics in Patients with Omicron and Delta Variants of SARS-CoV-2 in Beijing, China

被引:0
|
作者
Tian, Di [1 ]
Pan, Yang [2 ]
Ge, Ziruo [1 ]
Kong, Xiangjing [1 ]
Zhang, Yao [1 ]
Zhang, Qing [1 ]
Wang, Aibin [1 ]
Yang, Peng [2 ]
Chen, Zhihai [1 ]
机构
[1] Capital Med Univ, Beijing Ditan Hosp, Emergency Dept COVID 19, Beijing 100015, Peoples R China
[2] Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, Beijing 100013, Peoples R China
来源
INFECTIOUS DISEASES & IMMUNITY | 2023年 / 3卷 / 02期
关键词
SARS-CoV-2; Delta variant; Omicron variant; Clinical characteristics;
D O I
10.1097/ID9.0000000000000081
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Delta and Omicron are two main variants that have been prevalent since 2021. However, the Omicron variant of severe acute respiratory syndrome coronavirus 2 shows a less severe clinical presentation and high transmissibility. Therefore, we carried out this retrospective study to evaluate Omicron severity compared with the Delta variant and further comprehend the differences in clinical characteristics in patients with the Omicron variant. Methods: We extracted clinical data and compared clinical severity, symptoms, vaccination status, laboratory parameters, viral shedding time, and computed tomography (CT) imaging between the two groups of patients, which included 109 COVID-19 cases with the Delta variant and 183 cases with the Omicron variant, from January 19 to April 1, 2022, in Beijing Ditan Hospital. In addition, the Beijing Center for Disease Prevention and Control conducted whole-genome sequencing. Results: We obtained 94 strains of variants of concern/Delta and 110 strains of variants of concern/Omicron. For the 110 Omicron strains, three were assigned as BA.1.1, 53 as BA.2, and 54 as BA.2.2. Among patients with the Delta variant, 54% (59/109) were moderate, which was significantly higher than that of patients with the Omicron variant (7% (12/183), P < 0.001). The number of patients with mild symptoms in the Omicron group was significantly higher than in the Delta group (80% vs. 35%, P < 0.001). Compared with the Omicron group, patients with underlying diseases or obesity, 60 years or older, or unvaccinated in the Delta group had more severe disease, and there was a significant difference between the two groups. The viral shedding time in the Omicron group was shorter than in the Delta group ((11.9 +/- 5.9) vs. (14.0 +/- 5.8) days, P = 0.003). Among the 183 patients in the Omicron group, 104 (57%) had dry or sore throat symptoms, more than those in the Delta group (34% (37/109); P < 0.001). In the Delta group, patients in the moderate group had more fever and cough symptoms than those in the mild group. The remission time of CT imaging in the Omicron group was shorter than in the Delta group ((9.0 +/- 5.2) vs. (13.2 +/- 4.2) days, P = 0.018). Conclusions: Patients with Delta variants are more likely to have pneumonia, mainly with fever and cough symptoms, while patients with the Omicron variant are mostly mild, with more prominent dry or sore throat symptoms. In addition, patients with the Omicron variant have a short viral shedding time and rapid absorption of pneumonia.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [41] Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
    Antonelli, Michela
    Pujol, Joan Capdevila
    Spector, Tim D.
    Ourselin, Sebastien
    Steves, Claire J.
    LANCET, 2022, 399 (10343): : 2263 - 2264
  • [42] Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households
    Jorgensen, Silje B.
    Nygard, Karin
    Kacelnik, Oliver
    Telle, Kjetil
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (16): : 1610 - 1611
  • [43] Performance of nasopharyngeal swab and saliva in detecting Delta and Omicron SARS-CoV-2 variants
    Ursic, Tina
    Kogoj, Rok
    Sikonja, Jaka
    Roskaric, Damijana
    Virant, Monika Jevsnik
    Bogovic, Petra
    Petrovec, Miroslav
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4704 - 4711
  • [44] SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
    Keyel, Alexander C.
    Russell, Alexis
    Plitnick, Jonathan
    V. Rowlands, Jemma
    Lamson, Daryl M.
    Rosenberg, Eli
    George, Kirsten St.
    EMERGING INFECTIOUS DISEASES, 2022, 28 (10) : 1990 - 1998
  • [45] Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants
    Feng, Sheng
    Fan, Zechang
    Zhou, Keyue
    Ma, Shanshan
    Liang, Mingzheng
    Zhang, He
    Xie, Yubiao
    Ha, Zhuo
    Jin, Ningyi
    Lu, Huijun
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (10)
  • [46] A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
    Zhao, Hanjun
    To, Kelvin Kai-Wang
    Lam, Hoiyan
    Zhang, Chuyuan
    Peng, Zheng
    Meng, Xinjie
    Wang, Xiankun
    Zhang, Anna Jinxia
    Yan, Bingpeng
    Cai, Jianpiao
    Yeung, Man Lung
    Chan, Jasper Fuk-Woo
    Yuen, Kwok-Yung
    CELL DISCOVERY, 2022, 8 (01)
  • [47] Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore
    Zeng, Kangwei
    Santhya, Aijia
    Soong, Aijia
    Malhotra, Nitika
    Pushparajah, Dhanushanth
    Thoon, Koh Cheng
    Yeo, Benny
    Ho, Zheng Jie Marc
    I-Cheng, Mark Chen
    EMERGING INFECTIOUS DISEASES, 2023, 29 (04) : 814 - 817
  • [48] SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
    Regenhardt, Elisa
    Kirsten, Holger
    Weiss, Melanie
    Luebbert, Christoph
    Stehr, Sebastian N.
    Remane, Yvonne
    Pietsch, Corinna
    Hoenemann, Mario
    von Braun, Amrei
    VACCINES, 2023, 11 (05)
  • [49] Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
    Lee, Byung Uk
    AEROSOL AND AIR QUALITY RESEARCH, 2022, 22 (01)
  • [50] Omicron variants of SARS-CoV-2 and long COVID
    Yang, Chengliang
    Zhao, Hedi
    Shannon, Casey P.
    Tebbutt, Scott J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13